Save $20 on Adequan® i.m. PSGAG for a limited time

[HI-Logo] Get a jump on treatment before time runs out. Save $20 on your horse’s first 7-dose series of Adequan i.m. Ask your veterinarian about this first-of-its-kind offer on a one-of-a-kind treatment* today! Offer valid on first 7-dose series of Adequan® i.m. (polysulfated glycosaminoglycan) Injectable for Horses with a purchase of the 7-dose box or the 50 mL vial. Qualifying purchase(s) must be made during the promotion period of July 21, 2023 - October 31, 2023. Limit of one (1) submission per name, address or household. Maximum rebate of $20. Rebate requests must be received by December 31, 2023. To see full terms and conditions, visit grabmyrebate.com then enter code AET200723. Consult your veterinarian for diagnosis and treatment. FDA-approved to treat arthritis, not just its symptoms *As the only FDA-approved cartilage-restoring treatment for arthritis in horses, Adequan i.m. actually treats the disease, not just its symptoms.1,2 For over 30 years, veterinarians have given Adequan i.m. to help horses of every discipline enjoy greater mobility over their lifetimes.1,3,4 INDICATIONS Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan (PSGAG). Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, [click here.]( 1. Kim DY, Taylor HW, Moore RM, Paulsen DB, Cho DY. Articular chondrocyte apoptosis in equine osteoarthritis. The Veterinary Journal 2003; 166: 52-57. 2. McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48. 3. Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993; 13: 696-703. 4. Adequan® i.m. (polysulfated glycosaminoglycan), Package Insert. American Regent, Inc. All trademarks are the property of their respective owners. © 2023, American Regent, Inc. PP-AI-US-0994 This email was sent to {EMAIL} [why did I get this?]( [unsubscribe from this list]( [update subscription preferences]( EG Media Investments LLC · 3622 Lyckan Parkway Suite · 3003 Durham, NC 27707 · USA